Physician profile
Aleksandr Kravtsov
NPI 1326215542
$2,284.63
in general payments reported to CMS, 2019-2025
24 companies · $63.61 in 2025
The $63.61 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $182 · 2021: $219 · 2022: $106 · 2023: $1,398 · 2024: $59.83 · 2025: $63.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $1,355.50 | 2023 | Myrisk |
| Gynesonics, INC. | $176.76 | 2019 | |
| Abbvie INC. | $111.67 | 2021 | |
| Mylan Pharmaceuticals INC. | $109.37 | 2020-2021 | |
| Myovant Sciences INC. | $59.78 | 2022 | |
| Exeltis, USA INC. | $56.50 | 2020-2025 | Slynd |
| Shield Therapeutics INC | $43.54 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $40.89 | 2019-2020 | |
| Lupin INC. | $38.27 | 2020 | |
| Meridian Bioscience INC. | $28.93 | 2019 | |
| Evofem Biosciences, INC. | $26.99 | 2020-2021 | |
| Pfizer INC. | $23.96 | 2022 | |
| Vertical Pharmaceuticals, LLC | $22.73 | 2019 | |
| Hologic Sales and Service, LLC | $22.35 | 2025 | Aptima |
| Scynexis, INC. | $21.82 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $21.63 | 2024 | Kristalose |
| Sumitomo Pharma America, INC. | $21.53 | 2023 | Myfembree |
| Coopersurgical, INC. | $21.42 | 2023 | Paragard T 380a |
| Avion Pharmaceuticals | $14.57 | 2020 | |
| Virtus Pharmaceuticals LLC | $14.25 | 2021 | |
| Baudax Bio INC. | $13.92 | 2020 | |
| Agile Therapeutics, INC. | $13.29 | 2021 | |
| Therapeuticsmd, INC. | $13.13 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleksandr Kravtsov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.